Alvogen Pharmaceutical is a global pharmaceutical company mainly focused on developing, manufacturing and selling generic, brand, over-the-counter, and biosimilar products. It serves all the people around the world. It has commercial operations in 35 countries that operate five manufacturing and development hubs in the U.S., Romania, Korea and Taiwan.
The company’s leadership team is dedicated to promoting a dynamic change-driven culture committed to fulfill the needs of its customers. The structure is lean and flexible that drives quick and effective decision making. Therefore, the company is enabled to bring new generic products quickly and safely to market.
Alvogen Pharmaceutical has well established business include product development, contract manufacturing and research, and sales of generic medicines, biosimilars and OTC. It gives worthy and trustful solutions to meet the needs of people across the globe.
The portfolio of Alvogen Pharmaceutical consists of a wide range for the treatment of conditions in the areas of oncology, cardiology, respiratory, neurology, and gastroenterology, in addition to a fast-growing portfolio of biosimilars and OTC products.
This unique portfolio of high quality and challenging-to-make pharmaceutical products fuels the company’s targeted growth strategy. It offers high-quality, affordable generic medicines that help reduce healthcare costs around the world.